From October 1, 2023 to December 31, 2023, the company has repurchased 957,000 shares, representing 0.21% for $26.15 million. With this, the company has completed the repurchase of 9,846,000 shares, representing 2.19% for $304.77 million under the buyback announced on March 28, 2023.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
28.1 USD | -0.65% | +0.18% | +0.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.11% | 12.75B | |
+32.87% | 700B | |
-4.79% | 358B | |
+19.03% | 330B | |
+3.34% | 287B | |
+15.70% | 236B | |
+6.68% | 202B | |
-9.08% | 197B | |
+5.22% | 161B | |
-2.07% | 157B |
- Stock Market
- Equities
- RPRX Stock
- News Royalty Pharma plc
- Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.